Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126094421 | 12609442 | 1 | I | 20160715 | 0 | 20160729 | 20160729 | DIR | 6.79 | YR | M | N | 13.20000 | KG | 20160728 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126094421 | 12609442 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | D | D | 0 | 45 | MG | ||||||||
| 126094421 | 12609442 | 2 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 0 | 2.1 | MG | ||||||||||
| 126094421 | 12609442 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | 84 | MG | ||||||||||
| 126094421 | 12609442 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | 0 | 12 | MG | ||||||||||
| 126094421 | 12609442 | 5 | SS | ONCASPAR | PEGASPARGASE | 1 | 0 | 1550 | IU |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126094421 | 12609442 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126094421 | 12609442 | Ascites | |
| 126094421 | 12609442 | Blood bilirubin increased | |
| 126094421 | 12609442 | Blood culture positive | |
| 126094421 | 12609442 | Blood fibrinogen decreased | |
| 126094421 | 12609442 | Candida infection | |
| 126094421 | 12609442 | Chest X-ray abnormal | |
| 126094421 | 12609442 | Coagulopathy | |
| 126094421 | 12609442 | Device related infection | |
| 126094421 | 12609442 | Enterococcus test positive | |
| 126094421 | 12609442 | Fluid overload | |
| 126094421 | 12609442 | Heart sounds abnormal | |
| 126094421 | 12609442 | Hepatomegaly | |
| 126094421 | 12609442 | Pleural effusion | |
| 126094421 | 12609442 | Prothrombin time prolonged | |
| 126094421 | 12609442 | Pulse absent | |
| 126094421 | 12609442 | Respiratory distress | |
| 126094421 | 12609442 | Septic shock | |
| 126094421 | 12609442 | Venoocclusive disease | |
| 126094421 | 12609442 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126094421 | 12609442 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126094421 | 12609442 | 1 | 20160707 | 0 | ||
| 126094421 | 12609442 | 2 | 20160707 | 0 | ||
| 126094421 | 12609442 | 3 | 20160713 | 0 | ||
| 126094421 | 12609442 | 4 | 20160623 | 0 | ||
| 126094421 | 12609442 | 5 | 20160627 | 0 |